Potential of the Combination of a Systemic Enzyme Complex and Probiotics administration to Combat COVID-19: A Randomized Open Label Prospective Analysis
Journal Title: Advances in Clinical Toxicology - Year 2021, Vol 6, Issue 1
Abstract
Background: Enzymes have been used for therapeutic applications for decades owing to their anti-inflammatory and immunomodulatory effects. Probiotics are well known to reduce the incidence and severity of several health-related conditions. To our knowledge, no clinical trial has evaluated the effects of a combination of systemic enzyme and probiotic supplementation in Covid-19 patients infected with the SARSCoV-2 virus. Objective: We investigated the safety and efficacy of the health supplements ImmunoSEB (systemic enzyme complex) and ProbioSEB CSC3 (probiotic complex) as supplemental therapy in confirmed mild to moderate COVID-19 patients. Methods: A randomized, open label, 2-arm, prospective study in patients with an RT-PCR confirmed diagnosis of COVID-19 with a mild to moderate condition was conducted. The control arm (n=30) received standard of care (SOC) treatment and the test arm (n=30) received the oral supplements ImmunoSEB (500 mg/cap.) + ProbioSEB CSC3 (5 billion CFUs /cap.) for 14 days in addition to SOC. The efficacy and safety of the experimental regimen was compared with the control arm at various timepoints from days 1 to 21. Results: A significantly higher proportion of patients in the test arm showed clinical improvement on day 10 vs the controls (93.33% vs 60%; p<0.05). No adverse events were reported in the test arm at any time during the study suggesting the safety of supplementation with ImmunoSEB + ProbioSEB CSC3. Patients in the test arm also had a shorter duration of hospitalization, quicker recovery and faster reduction in CRP levels as compared to the control arm. Conclusions: The present study concludes that supplemental therapy with ImmunoSEB + ProbioSEB CSC3 accelerates clinical improvement in mild to moderate COVID-19 patients. While there is no vaccine or specific drug to completely cure SARS CoV-2 infection, the proposed supplemental therapy could be a potential tool to aid in the recovery of COVID-19 of patients.
Authors and Affiliations
Neha Shah*, Rohit Parate and Abhay Vispute
Keywords
Related Articles
- EP ID EP751772
- DOI 10.23880/act-16000205
- Views 27
- Downloads 0
Alterations in the Air Pollution Tolerance Indices and Foliar Micro-Structures of Five Medicinal Plants: Implications of OilSpill Pollution of Agricultural Farmland in Edugberi Community, Rivers State, Nigeria
The Nigerian costal environment has witnessed the continuous input of petroleum hydrocarbons and associated pollutants as a result of different phases of petroleum activities. These activities have elicited a devastatin...
Biochemical Effect of Artemisin-based Combination Therapy (ACT) Antimalarial Drugs on Enzymatic Antioxidants in Pregnancy
This study was undertaken to determine the effect of artemisin-based combination therapy (ACT) on Plasma enzymatic antioxidants in pregnant women with malaria. Seventy-five (75) consenting pregnant subjects (25malarial...
Suppression of Hyperglycemia-Induced Insulin Resistance by Rapanone Isolated from Connarus Ruber
Although it would be ideal if insulin resistance due to a persistent hyperglycemic state could be prevented by consuming particular foods, to the best of our knowledge, no foods with such effects have as yet been reporte...
Phenylenediamine Poisoning: Beyond the Respiratory Distress
The paraphénylèdiamine or PPD is a black coloring agent entering the composition of hair colorings, essentially used in hairstyle as dye for hair, but also in the temporary tattoos, in association with the henna. It is...
The Menace of Lead Poisoning in Pakistan
Environmental pollution has been increased many times due to increase in population, industrialization and urbanization; in some places, it becomes toxic to living organisms. Among the pollutants, heavy metals pose th...